Industry Research Reports

Home > Reports > Service & Software > Supplement CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Supplement CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-06-06

Pages: 109 Pages

Report ld: 4756684

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Supplement CDMO Market Size(US$)

CAGR 2025-2031

6.5%

Market Size,2031

USD 18,660

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 12,790 million

Market Forecast in 2031(Value)

US$ 18,660 million

CAGR

6.5%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Supplement CDMO was estimated to be worth US$ 12010 million in 2024 and is forecast to a readjusted size of US$ 18660 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.

Supplement CDMO refers to a professional organization that provides one-stop outsourcing services such as R&D, formula optimization, clinical trial support, large-scale production and packaging for health products (such as dietary supplements, functional foods, nutritional preparations, etc.). This model helps brands reduce R&D investment, accelerate product launch, and meet compliance requirements in the global market.

North American market for Supplement CDMO was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Supplement CDMO was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Supplement CDMO was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Supplement CDMO include Biofarma Group, SFI Health Solutions, TCI Bio, Lonza, HERMES PHARMA, AGC Biologics, Vitaquest, Catalent, KD Pharma Group, Pharma Tech Industries, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Supplement CDMO, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Supplement CDMO by region & country, by Type, and by Application.

The Supplement CDMO market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Supplement CDMO.

MARKET SEGMENTATION

By Company

Biofarma Group
SFI Health Solutions
TCI Bio
Lonza
HERMES PHARMA
AGC Biologics
Vitaquest
Catalent
KD Pharma Group
Pharma Tech Industries
CordenPharma
Pierre Fabre
NutraPak USA
American Health Formulations
Alora Pharmaceuticals

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

‌Small Molecule CDMO‌
‌Large Molecule CDMO‌

Segment by Application

Solid Dosage Form
Liquid Dosage Form
Powder
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Supplement CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Supplement CDMO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Supplement CDMO in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Supplement CDMO Product Introduction

1.2 Global Supplement CDMO Market Size Forecast (2020-2031)

1.3 Supplement CDMO Market Trends & Drivers

1.3.1 Supplement CDMO Industry Trends

1.3.2 Supplement CDMO Market Drivers & Opportunity

1.3.3 Supplement CDMO Market Challenges

1.3.4 Supplement CDMO Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Supplement CDMO Players Revenue Ranking (2024)

2.2 Global Supplement CDMO Revenue by Company (2020-2025)

2.3 Key Companies Supplement CDMO Manufacturing Base Distribution and Headquarters

2.4 Key Companies Supplement CDMO Product Offered

2.5 Key Companies Time to Begin Mass Production of Supplement CDMO

2.6 Supplement CDMO Market Competitive Analysis

2.6.1 Supplement CDMO Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Supplement CDMO Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Supplement CDMO as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 ‌Small Molecule CDMO‌

3.1.2 ‌Large Molecule CDMO‌

3.2 Global Supplement CDMO Sales Value by Type

3.2.1 Global Supplement CDMO Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Supplement CDMO Sales Value, by Type (2020-2031)

3.2.3 Global Supplement CDMO Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Solid Dosage Form

4.1.2 Liquid Dosage Form

4.1.3 Powder

4.1.4 Others

4.2 Global Supplement CDMO Sales Value by Application

4.2.1 Global Supplement CDMO Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Supplement CDMO Sales Value, by Application (2020-2031)

4.2.3 Global Supplement CDMO Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global Supplement CDMO Sales Value by Region

5.1.1 Global Supplement CDMO Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Supplement CDMO Sales Value by Region (2020-2025)

5.1.3 Global Supplement CDMO Sales Value by Region (2026-2031)

5.1.4 Global Supplement CDMO Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Supplement CDMO Sales Value, 2020-2031

5.2.2 North America Supplement CDMO Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Supplement CDMO Sales Value, 2020-2031

5.3.2 Europe Supplement CDMO Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Supplement CDMO Sales Value, 2020-2031

5.4.2 Asia Pacific Supplement CDMO Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Supplement CDMO Sales Value, 2020-2031

5.5.2 South America Supplement CDMO Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Supplement CDMO Sales Value, 2020-2031

5.6.2 Middle East & Africa Supplement CDMO Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Supplement CDMO Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Supplement CDMO Sales Value, 2020-2031

6.3 United States

6.3.1 United States Supplement CDMO Sales Value, 2020-2031

6.3.2 United States Supplement CDMO Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Supplement CDMO Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Supplement CDMO Sales Value, 2020-2031

6.4.2 Europe Supplement CDMO Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Supplement CDMO Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Supplement CDMO Sales Value, 2020-2031

6.5.2 China Supplement CDMO Sales Value by Type (%), 2024 VS 2031

6.5.3 China Supplement CDMO Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Supplement CDMO Sales Value, 2020-2031

6.6.2 Japan Supplement CDMO Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Supplement CDMO Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Supplement CDMO Sales Value, 2020-2031

6.7.2 South Korea Supplement CDMO Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Supplement CDMO Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Supplement CDMO Sales Value, 2020-2031

6.8.2 Southeast Asia Supplement CDMO Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Supplement CDMO Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Supplement CDMO Sales Value, 2020-2031

6.9.2 India Supplement CDMO Sales Value by Type (%), 2024 VS 2031

6.9.3 India Supplement CDMO Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Biofarma Group

7.1.1 Biofarma Group Profile

7.1.2 Biofarma Group Main Business

7.1.3 Biofarma Group Supplement CDMO Products, Services and Solutions

7.1.4 Biofarma Group Supplement CDMO Revenue (US$ Million) & (2020-2025)

7.1.5 Biofarma Group Recent Developments

7.2 SFI Health Solutions

7.2.1 SFI Health Solutions Profile

7.2.2 SFI Health Solutions Main Business

7.2.3 SFI Health Solutions Supplement CDMO Products, Services and Solutions

7.2.4 SFI Health Solutions Supplement CDMO Revenue (US$ Million) & (2020-2025)

7.2.5 SFI Health Solutions Recent Developments

7.3 TCI Bio

7.3.1 TCI Bio Profile

7.3.2 TCI Bio Main Business

7.3.3 TCI Bio Supplement CDMO Products, Services and Solutions

7.3.4 TCI Bio Supplement CDMO Revenue (US$ Million) & (2020-2025)

7.3.5 TCI Bio Recent Developments

7.4 Lonza

7.4.1 Lonza Profile

7.4.2 Lonza Main Business

7.4.3 Lonza Supplement CDMO Products, Services and Solutions

7.4.4 Lonza Supplement CDMO Revenue (US$ Million) & (2020-2025)

7.4.5 Lonza Recent Developments

7.5 HERMES PHARMA

7.5.1 HERMES PHARMA Profile

7.5.2 HERMES PHARMA Main Business

7.5.3 HERMES PHARMA Supplement CDMO Products, Services and Solutions

7.5.4 HERMES PHARMA Supplement CDMO Revenue (US$ Million) & (2020-2025)

7.5.5 HERMES PHARMA Recent Developments

7.6 AGC Biologics

7.6.1 AGC Biologics Profile

7.6.2 AGC Biologics Main Business

7.6.3 AGC Biologics Supplement CDMO Products, Services and Solutions

7.6.4 AGC Biologics Supplement CDMO Revenue (US$ Million) & (2020-2025)

7.6.5 AGC Biologics Recent Developments

7.7 Vitaquest

7.7.1 Vitaquest Profile

7.7.2 Vitaquest Main Business

7.7.3 Vitaquest Supplement CDMO Products, Services and Solutions

7.7.4 Vitaquest Supplement CDMO Revenue (US$ Million) & (2020-2025)

7.7.5 Vitaquest Recent Developments

7.8 Catalent

7.8.1 Catalent Profile

7.8.2 Catalent Main Business

7.8.3 Catalent Supplement CDMO Products, Services and Solutions

7.8.4 Catalent Supplement CDMO Revenue (US$ Million) & (2020-2025)

7.8.5 Catalent Recent Developments

7.9 KD Pharma Group

7.9.1 KD Pharma Group Profile

7.9.2 KD Pharma Group Main Business

7.9.3 KD Pharma Group Supplement CDMO Products, Services and Solutions

7.9.4 KD Pharma Group Supplement CDMO Revenue (US$ Million) & (2020-2025)

7.9.5 KD Pharma Group Recent Developments

7.10 Pharma Tech Industries

7.10.1 Pharma Tech Industries Profile

7.10.2 Pharma Tech Industries Main Business

7.10.3 Pharma Tech Industries Supplement CDMO Products, Services and Solutions

7.10.4 Pharma Tech Industries Supplement CDMO Revenue (US$ Million) & (2020-2025)

7.10.5 Pharma Tech Industries Recent Developments

7.11 CordenPharma

7.11.1 CordenPharma Profile

7.11.2 CordenPharma Main Business

7.11.3 CordenPharma Supplement CDMO Products, Services and Solutions

7.11.4 CordenPharma Supplement CDMO Revenue (US$ Million) & (2020-2025)

7.11.5 CordenPharma Recent Developments

7.12 Pierre Fabre

7.12.1 Pierre Fabre Profile

7.12.2 Pierre Fabre Main Business

7.12.3 Pierre Fabre Supplement CDMO Products, Services and Solutions

7.12.4 Pierre Fabre Supplement CDMO Revenue (US$ Million) & (2020-2025)

7.12.5 Pierre Fabre Recent Developments

7.13 NutraPak USA

7.13.1 NutraPak USA Profile

7.13.2 NutraPak USA Main Business

7.13.3 NutraPak USA Supplement CDMO Products, Services and Solutions

7.13.4 NutraPak USA Supplement CDMO Revenue (US$ Million) & (2020-2025)

7.13.5 NutraPak USA Recent Developments

7.14 American Health Formulations

7.14.1 American Health Formulations Profile

7.14.2 American Health Formulations Main Business

7.14.3 American Health Formulations Supplement CDMO Products, Services and Solutions

7.14.4 American Health Formulations Supplement CDMO Revenue (US$ Million) & (2020-2025)

7.14.5 American Health Formulations Recent Developments

7.15 Alora Pharmaceuticals

7.15.1 Alora Pharmaceuticals Profile

7.15.2 Alora Pharmaceuticals Main Business

7.15.3 Alora Pharmaceuticals Supplement CDMO Products, Services and Solutions

7.15.4 Alora Pharmaceuticals Supplement CDMO Revenue (US$ Million) & (2020-2025)

7.15.5 Alora Pharmaceuticals Recent Developments

8 Industry Chain Analysis

8.1 Supplement CDMO Industrial Chain

8.2 Supplement CDMO Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Supplement CDMO Sales Model

8.5.2 Sales Channel

8.5.3 Supplement CDMO Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Supplement CDMO Market Trends

Table 2. Supplement CDMO Market Drivers & Opportunity

Table 3. Supplement CDMO Market Challenges

Table 4. Supplement CDMO Market Restraints

Table 5. Global Supplement CDMO Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Supplement CDMO Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Supplement CDMO Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Supplement CDMO Product Type

Table 9. Key Companies Time to Begin Mass Production of Supplement CDMO

Table 10. Global Supplement CDMO Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Supplement CDMO as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Supplement CDMO Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Supplement CDMO Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Supplement CDMO Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Supplement CDMO Sales Market Share in Value by Type (2020-2025)

Table 17. Global Supplement CDMO Sales Market Share in Value by Type (2026-2031)

Table 18. Global Supplement CDMO Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Supplement CDMO Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Supplement CDMO Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Supplement CDMO Sales Market Share in Value by Application (2020-2025)

Table 22. Global Supplement CDMO Sales Market Share in Value by Application (2026-2031)

Table 23. Global Supplement CDMO Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Supplement CDMO Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Supplement CDMO Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Supplement CDMO Sales Value by Region (2020-2025) & (%)

Table 27. Global Supplement CDMO Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Supplement CDMO Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Supplement CDMO Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Supplement CDMO Sales Value, (2026-2031) & (US$ Million)

Table 31. Biofarma Group Basic Information List

Table 32. Biofarma Group Description and Business Overview

Table 33. Biofarma Group Supplement CDMO Products, Services and Solutions

Table 34. Revenue (US$ Million) in Supplement CDMO Business of Biofarma Group (2020-2025)

Table 35. Biofarma Group Recent Developments

Table 36. SFI Health Solutions Basic Information List

Table 37. SFI Health Solutions Description and Business Overview

Table 38. SFI Health Solutions Supplement CDMO Products, Services and Solutions

Table 39. Revenue (US$ Million) in Supplement CDMO Business of SFI Health Solutions (2020-2025)

Table 40. SFI Health Solutions Recent Developments

Table 41. TCI Bio Basic Information List

Table 42. TCI Bio Description and Business Overview

Table 43. TCI Bio Supplement CDMO Products, Services and Solutions

Table 44. Revenue (US$ Million) in Supplement CDMO Business of TCI Bio (2020-2025)

Table 45. TCI Bio Recent Developments

Table 46. Lonza Basic Information List

Table 47. Lonza Description and Business Overview

Table 48. Lonza Supplement CDMO Products, Services and Solutions

Table 49. Revenue (US$ Million) in Supplement CDMO Business of Lonza (2020-2025)

Table 50. Lonza Recent Developments

Table 51. HERMES PHARMA Basic Information List

Table 52. HERMES PHARMA Description and Business Overview

Table 53. HERMES PHARMA Supplement CDMO Products, Services and Solutions

Table 54. Revenue (US$ Million) in Supplement CDMO Business of HERMES PHARMA (2020-2025)

Table 55. HERMES PHARMA Recent Developments

Table 56. AGC Biologics Basic Information List

Table 57. AGC Biologics Description and Business Overview

Table 58. AGC Biologics Supplement CDMO Products, Services and Solutions

Table 59. Revenue (US$ Million) in Supplement CDMO Business of AGC Biologics (2020-2025)

Table 60. AGC Biologics Recent Developments

Table 61. Vitaquest Basic Information List

Table 62. Vitaquest Description and Business Overview

Table 63. Vitaquest Supplement CDMO Products, Services and Solutions

Table 64. Revenue (US$ Million) in Supplement CDMO Business of Vitaquest (2020-2025)

Table 65. Vitaquest Recent Developments

Table 66. Catalent Basic Information List

Table 67. Catalent Description and Business Overview

Table 68. Catalent Supplement CDMO Products, Services and Solutions

Table 69. Revenue (US$ Million) in Supplement CDMO Business of Catalent (2020-2025)

Table 70. Catalent Recent Developments

Table 71. KD Pharma Group Basic Information List

Table 72. KD Pharma Group Description and Business Overview

Table 73. KD Pharma Group Supplement CDMO Products, Services and Solutions

Table 74. Revenue (US$ Million) in Supplement CDMO Business of KD Pharma Group (2020-2025)

Table 75. KD Pharma Group Recent Developments

Table 76. Pharma Tech Industries Basic Information List

Table 77. Pharma Tech Industries Description and Business Overview

Table 78. Pharma Tech Industries Supplement CDMO Products, Services and Solutions

Table 79. Revenue (US$ Million) in Supplement CDMO Business of Pharma Tech Industries (2020-2025)

Table 80. Pharma Tech Industries Recent Developments

Table 81. CordenPharma Basic Information List

Table 82. CordenPharma Description and Business Overview

Table 83. CordenPharma Supplement CDMO Products, Services and Solutions

Table 84. Revenue (US$ Million) in Supplement CDMO Business of CordenPharma (2020-2025)

Table 85. CordenPharma Recent Developments

Table 86. Pierre Fabre Basic Information List

Table 87. Pierre Fabre Description and Business Overview

Table 88. Pierre Fabre Supplement CDMO Products, Services and Solutions

Table 89. Revenue (US$ Million) in Supplement CDMO Business of Pierre Fabre (2020-2025)

Table 90. Pierre Fabre Recent Developments

Table 91. NutraPak USA Basic Information List

Table 92. NutraPak USA Description and Business Overview

Table 93. NutraPak USA Supplement CDMO Products, Services and Solutions

Table 94. Revenue (US$ Million) in Supplement CDMO Business of NutraPak USA (2020-2025)

Table 95. NutraPak USA Recent Developments

Table 96. American Health Formulations Basic Information List

Table 97. American Health Formulations Description and Business Overview

Table 98. American Health Formulations Supplement CDMO Products, Services and Solutions

Table 99. Revenue (US$ Million) in Supplement CDMO Business of American Health Formulations (2020-2025)

Table 100. American Health Formulations Recent Developments

Table 101. Alora Pharmaceuticals Basic Information List

Table 102. Alora Pharmaceuticals Description and Business Overview

Table 103. Alora Pharmaceuticals Supplement CDMO Products, Services and Solutions

Table 104. Revenue (US$ Million) in Supplement CDMO Business of Alora Pharmaceuticals (2020-2025)

Table 105. Alora Pharmaceuticals Recent Developments

Table 106. Key Raw Materials Lists

Table 107. Raw Materials Key Suppliers Lists

Table 108. Supplement CDMO Downstream Customers

Table 109. Supplement CDMO Distributors List

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

List of Figures

Figure 1. Supplement CDMO Product Picture

Figure 2. Global Supplement CDMO Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Supplement CDMO Sales Value (2020-2031) & (US$ Million)

Figure 4. Supplement CDMO Report Years Considered

Figure 5. Global Supplement CDMO Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Supplement CDMO Revenue in 2024

Figure 7. Supplement CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. ‌Small Molecule CDMO‌ Picture

Figure 9. ‌Large Molecule CDMO‌ Picture

Figure 10. Global Supplement CDMO Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 11. Global Supplement CDMO Sales Value Market Share by Type, 2024 & 2031

Figure 12. Product Picture of Solid Dosage Form

Figure 13. Product Picture of Liquid Dosage Form

Figure 14. Product Picture of Powder

Figure 15. Product Picture of Others

Figure 16. Global Supplement CDMO Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 17. Global Supplement CDMO Sales Value Market Share by Application, 2024 & 2031

Figure 18. North America Supplement CDMO Sales Value (2020-2031) & (US$ Million)

Figure 19. North America Supplement CDMO Sales Value by Country (%), 2024 VS 2031

Figure 20. Europe Supplement CDMO Sales Value, (2020-2031) & (US$ Million)

Figure 21. Europe Supplement CDMO Sales Value by Country (%), 2024 VS 2031

Figure 22. Asia Pacific Supplement CDMO Sales Value, (2020-2031) & (US$ Million)

Figure 23. Asia Pacific Supplement CDMO Sales Value by Region (%), 2024 VS 2031

Figure 24. South America Supplement CDMO Sales Value, (2020-2031) & (US$ Million)

Figure 25. South America Supplement CDMO Sales Value by Country (%), 2024 VS 2031

Figure 26. Middle East & Africa Supplement CDMO Sales Value, (2020-2031) & (US$ Million)

Figure 27. Middle East & Africa Supplement CDMO Sales Value by Country (%), 2024 VS 2031

Figure 28. Key Countries/Regions Supplement CDMO Sales Value (%), (2020-2031)

Figure 29. United States Supplement CDMO Sales Value, (2020-2031) & (US$ Million)

Figure 30. United States Supplement CDMO Sales Value by Type (%), 2024 VS 2031

Figure 31. United States Supplement CDMO Sales Value by Application (%), 2024 VS 2031

Figure 32. Europe Supplement CDMO Sales Value, (2020-2031) & (US$ Million)

Figure 33. Europe Supplement CDMO Sales Value by Type (%), 2024 VS 2031

Figure 34. Europe Supplement CDMO Sales Value by Application (%), 2024 VS 2031

Figure 35. China Supplement CDMO Sales Value, (2020-2031) & (US$ Million)

Figure 36. China Supplement CDMO Sales Value by Type (%), 2024 VS 2031

Figure 37. China Supplement CDMO Sales Value by Application (%), 2024 VS 2031

Figure 38. Japan Supplement CDMO Sales Value, (2020-2031) & (US$ Million)

Figure 39. Japan Supplement CDMO Sales Value by Type (%), 2024 VS 2031

Figure 40. Japan Supplement CDMO Sales Value by Application (%), 2024 VS 2031

Figure 41. South Korea Supplement CDMO Sales Value, (2020-2031) & (US$ Million)

Figure 42. South Korea Supplement CDMO Sales Value by Type (%), 2024 VS 2031

Figure 43. South Korea Supplement CDMO Sales Value by Application (%), 2024 VS 2031

Figure 44. Southeast Asia Supplement CDMO Sales Value, (2020-2031) & (US$ Million)

Figure 45. Southeast Asia Supplement CDMO Sales Value by Type (%), 2024 VS 2031

Figure 46. Southeast Asia Supplement CDMO Sales Value by Application (%), 2024 VS 2031

Figure 47. India Supplement CDMO Sales Value, (2020-2031) & (US$ Million)

Figure 48. India Supplement CDMO Sales Value by Type (%), 2024 VS 2031

Figure 49. India Supplement CDMO Sales Value by Application (%), 2024 VS 2031

Figure 50. Supplement CDMO Industrial Chain

Figure 51. Supplement CDMO Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 6.5% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

What was the global market size of Supplement CDMO in 2025? shouQi

Which companies rank high in the global Supplement CDMO market? shouQi

What was the global market size of Supplement CDMO in 2031? shouQi

What is the annual compound growth rate of the global Supplement CDMO market size from 2025 to 2031? shouQi

Related Reports

Global Supplement CDMO Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Supplement CDMO market is projected to grow from US$ 37765 million in 2025 to US$ 58409 million by 2032, at a CAGR of 6.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-16
Pages: 166
USD 4900.00
(Single User License)
Global Supplement CDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Supplement CDMO market size was US$ 37765 million in 2025 and is forecast to reach a readjusted size of US$ 58409 million by 2032 with a CAGR of 6.5% during the forecast period 2026-2032.
Published Date: 2026-08-16
Pages: 156
USD 4250.00
(Single User License)
Supplement CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Supplement CDMO was estimated to be worth US$ 37765 million in 2025 and is projected to reach US$ 58409 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-08-16
Pages: 142
USD 3950.00
(Single User License)
Global Supplement CDMO Market Research Report 2026
The global Supplement CDMO market was valued at US$ 37765 million in 2025 and is anticipated to reach US$ 58409 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-08-16
Pages: 152
USD 2900.00
(Single User License)
Global Supplement CDMO Market Research Report 2025
The global market for Supplement CDMO was valued at US$ 12010 million in the year 2024 and is projected to reach a revised size of US$ 18660 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published Date: 2025-06-06
Pages: 83
USD 2900.00
(Single User License)
Global Supplement CDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Supplement CDMO market size was US$ 12010 million in 2024 and is forecast to a readjusted size of US$ 18660 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-06-06
Pages: 93
USD 4250.00
(Single User License)
Global Supplement CDMO Market Insights, Forecast to 2031
The global Supplement CDMO market is projected to grow from US$ 12790 million in 2025 to US$ 18660 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period.
Published Date: 2025-06-06
Pages: 131
USD 4900.00
(Single User License)

Global Supplement CDMO Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Supplement CDMO market is projected to grow from US$ 37765 million in 2025 to US$ 58409 million by 2032, at a CAGR of 6.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-16
Pages: 166
USD 4900.00 (Single User License)
Global Supplement CDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Supplement CDMO market size was US$ 37765 million in 2025 and is forecast to reach a readjusted size of US$ 58409 million by 2032 with a CAGR of 6.5% during the forecast period 2026-2032.
Published: 2026-08-16
Pages: 156
USD 4250.00 (Single User License)
Supplement CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Supplement CDMO was estimated to be worth US$ 37765 million in 2025 and is projected to reach US$ 58409 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-08-16
Pages: 142
USD 3950.00 (Single User License)
Global Supplement CDMO Market Research Report 2026
The global Supplement CDMO market was valued at US$ 37765 million in 2025 and is anticipated to reach US$ 58409 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-08-16
Pages: 152
USD 2900.00 (Single User License)
Global Supplement CDMO Market Research Report 2025
The global market for Supplement CDMO was valued at US$ 12010 million in the year 2024 and is projected to reach a revised size of US$ 18660 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published: 2025-06-06
Pages: 83
USD 2900.00 (Single User License)
Global Supplement CDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Supplement CDMO market size was US$ 12010 million in 2024 and is forecast to a readjusted size of US$ 18660 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-06-06
Pages: 93
USD 4250.00 (Single User License)
Global Supplement CDMO Market Insights, Forecast to 2031
The global Supplement CDMO market is projected to grow from US$ 12790 million in 2025 to US$ 18660 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period.
Published: 2025-06-06
Pages: 131
USD 4900.00 (Single User License)